Treatment Options for Rosacea
The most effective treatment for rosacea is a phenotype-based approach using topical ivermectin 1% cream, azelaic acid 15% gel/foam, or the newly FDA-approved encapsulated benzoyl peroxide 5% (E-BPO 5%) as first-line therapies for inflammatory lesions, with brimonidine or oxymetazoline for persistent erythema. 1
First-Line Treatment Based on Phenotype
For Inflammatory Papules/Pustules:
- Topical ivermectin 1% cream is recommended as first-line therapy for mild inflammatory papules/pustules 1
- Topical azelaic acid 15% gel/foam is an effective alternative first-line option 2, 1
- Encapsulated benzoyl peroxide 5% (E-BPO 5%) shows rapid improvement by week 2 and sustained efficacy for up to 52 weeks 3, 4
- Topical metronidazole (0.75% and 1.0% formulations) produces up to 65% decrease in inflammatory lesion counts 4
- Topical minocycline foam 1.5% is recommended for moderate to severe inflammatory lesions 2, 1
For Persistent Erythema:
- Topical α-adrenergics, specifically brimonidine, are first-line therapy 3, 1
- Topical oxymetazoline is an effective alternative option 4, 1
- Physical modalities like IPL or PDL can be considered for persistent erythema 4
Combination Therapy Approach
- For moderate inflammatory papules/pustules, combine topical therapy with oral doxycycline for faster control 3, 2
- For severe inflammatory lesions, topical ivermectin plus oral doxycycline is recommended 4
- Multiple cutaneous features of rosacea can be treated with more than one agent simultaneously 2, 4
- Moderate and severe presentations typically require combination treatments 1
Oral Therapies
- Oral doxycycline is effective for all severities of inflammatory papules/pustules, clinically inflamed phyma, and ocular features 3
- Anti-inflammatory dose doxycycline (40-mg modified-release) has reduced gastrointestinal side effects and no antibiotic activity, making it preferable when available 3
- Other tetracycline antibiotics may be considered when doxycycline is unsuitable or unavailable 3
Maintenance Therapy
- The minimum treatment necessary to maintain control should be used 2, 1
- Without maintenance therapy, up to two-thirds of patients may relapse when treatment is discontinued 4, 1
- Approach to maintenance depends on treatment modality and patient desire for ongoing therapy 1
General Skincare Measures
- Sun protection (SPF 30+) is essential 4, 1
- Use gentle cleansers and moisturizers 4, 1
- Avoid trigger factors, though limited RCT evidence exists for this approach 1
Special Considerations for Ocular Rosacea
- Lid hygiene and artificial tears are recommended for mild ocular symptoms 1
- Oral doxycycline is recommended for moderate to severe cases of ocular rosacea 3, 1
- Ophthalmological referral should be considered for all but the mildest ocular features 1
Common Pitfalls and Caveats
- Insufficient treatment duration can lead to inadequate demonstration of efficacy; treatments should be given 6-12 weeks before considering them failures 3, 1
- Treating based on traditional subtypes rather than phenotypes may lead to inadequate management 1
- Poor adherence due to skin irritation can result in up to 89% of patients discontinuing therapy within a month 4
- Overlooking maintenance therapy can lead to relapse 4, 1
- Ignoring ocular manifestations can lead to underdiagnosis and undertreatment of ocular rosacea 1